List of Contributors |
|
xv | |
Preface |
|
xvii | |
Acknowledgements |
|
xix | |
1 Overview of Functional Foods |
|
1 | (14) |
|
|
|
|
|
1.1 Overview of Functional Foods |
|
|
1 | (5) |
|
1.1.1 Foods and Nutrients are Linked to Health and Disease |
|
|
1 | (1) |
|
1.1.2 Definition of Functional Foods |
|
|
2 | (1) |
|
1.1.3 Functional Foods Market |
|
|
2 | (1) |
|
1.1.4 How Functional Foods are Studied |
|
|
3 | (3) |
|
1.2 Functional Foods and their Regulatory Aspects |
|
|
6 | (1) |
|
1.3 Nanotechnologies in Functional Foods |
|
|
7 | (2) |
|
1.4 Sensory Functionalities of Foods |
|
|
9 | (2) |
|
|
11 | (4) |
2 The In vivo Foundations for In vitro Testing of Functional Foods: The Gastrointestinal System |
|
15 | (38) |
|
|
|
|
|
|
15 | (1) |
|
2.2 Overview of the Structure of the Gastrointestinal Tract |
|
|
16 | (4) |
|
|
17 | (1) |
|
|
17 | (1) |
|
2.2.3 Muscularis (or Muscularis Propria) and Serosa (or Adventitia) |
|
|
18 | (1) |
|
2.2.4 Additional Components of the Gastrointestinal Tract: Accessory Organs, Vasculature, Innervation, Gut-Associated Lymphoid Tissue, and Microbiome |
|
|
18 | (2) |
|
2.2.4.1 Accessory Organs of the GIT |
|
|
18 | (1) |
|
2.2.4.2 Vasculature of the GIT: Blood and Lymphatic Supply |
|
|
19 | (1) |
|
|
19 | (1) |
|
2.2.4.4 Gut-Associated Lymphoid Tissue |
|
|
19 | (1) |
|
2.2.4.5 Intestinal Microbiome |
|
|
20 | (1) |
|
2.3 Functions of the GIT and Associated In vitro Modeling |
|
|
20 | (18) |
|
|
21 | (3) |
|
2.3.1.1 The Foundations of GIT Motility: Smooth Muscle Cell Contractions (SMC) and ENS Regulation |
|
|
22 | (1) |
|
2.3.1.2 In vitro Motility Modeling |
|
|
23 | (1) |
|
2.3.2 Barrier Function, Secretion, and Absorption |
|
|
24 | (8) |
|
2.3.2.1 Tight Junctions and the Barrier Function of the GIT |
|
|
25 | (1) |
|
2.3.2.2 Intestinal Permeability: Definitions and the Role of Tight Junctions |
|
|
26 | (1) |
|
2.3.2.3 Influences on Permeability |
|
|
26 | (1) |
|
2.3.2.4 Absorption and Secretion |
|
|
27 | (1) |
|
2.3.2.5 In vitro Models of Barrier Function, Absorption, and Secretion |
|
|
28 | (4) |
|
2.3.3 Regulation of Immune Response |
|
|
32 | (3) |
|
2.3.3.1 The Mucosal Immune Response Depends on IECs and GALT |
|
|
32 | (1) |
|
2.3.3.2 Antigen Exclusion: The Importance of Secretory IgA |
|
|
32 | (1) |
|
2.3.3.3 Antigen Sampling is Necessary for Immune Homeostasis |
|
|
33 | (1) |
|
2.3.3.4 Antigen Presenting Cells and IECs Modulate T-cell Adaptive Immune Responses |
|
|
34 | (1) |
|
2.3.3.5 In vitro Models of Mucosal Immunity |
|
|
34 | (1) |
|
2.3.4 Storage, Fermentation, and Removal of Fecal Matter |
|
|
35 | (19) |
|
2.3.4.1 Storage and Removal of Fecal Matter |
|
|
35 | (1) |
|
2.3.4.2 Colonic Fermentation |
|
|
36 | (1) |
|
2.3.4.3 Short-Chain Fatty Acids |
|
|
37 | (1) |
|
2.3.4.4 In vitro Models of Fermentation |
|
|
37 | (1) |
|
2.4 Limitations of In vitro Modeling of the Gastrointestinal Tract |
|
|
38 | (2) |
|
2.5 Dynamic In vitro Models of Digestion |
|
|
40 | (1) |
|
|
40 | (1) |
|
|
41 | (12) |
3 In vivo Foundations of Sensory In vitro Testing Systems |
|
53 | (34) |
|
|
|
53 | (1) |
|
|
54 | (11) |
|
|
54 | (1) |
|
|
55 | (3) |
|
|
58 | (1) |
|
3.2.4 Transduction Mechanisms |
|
|
58 | (5) |
|
|
58 | (1) |
|
|
59 | (1) |
|
|
60 | (1) |
|
|
60 | (1) |
|
|
61 | (1) |
|
|
62 | (1) |
|
3.2.4.7 Downstream Signaling of T1R and T2R |
|
|
62 | (1) |
|
3.2.5 Non-Canonical Taste Modalities |
|
|
63 | (2) |
|
|
63 | (1) |
|
|
64 | (1) |
|
3.3 Factors that Influence Taste Acuity |
|
|
65 | (1) |
|
|
65 | (1) |
|
3.3.2 Genetic Differences |
|
|
66 | (1) |
|
|
66 | (1) |
|
|
67 | (3) |
|
|
68 | (1) |
|
3.5.2 Olfactory Binding Proteins |
|
|
68 | (1) |
|
3.5.3 Olfactory Receptors |
|
|
69 | (1) |
|
3.5.4 Transduction Mechanisms |
|
|
70 | (1) |
|
|
70 | (3) |
|
|
71 | (1) |
|
|
71 | (1) |
|
3.6.3 Periodontal Receptors |
|
|
72 | (1) |
|
3.6.4 Central Processing of Texture |
|
|
72 | (1) |
|
3.7 Convergence of Taste, Smell and Texture to Produce Flavor |
|
|
73 | (1) |
|
|
73 | (1) |
|
|
74 | (13) |
4 In vitro Models of Host-Microbial Interactions Within the Gastrointestinal Tract |
|
87 | (50) |
|
|
|
|
4.1 Introduction: The Human Gastrointestinal Tract |
|
|
87 | (4) |
|
4.2 The Current State of In vitro Model Systems to Model Gut Ecosystems |
|
|
91 | (2) |
|
4.3 Batch Culture Systems to Model the Gut Microbial Consortium |
|
|
93 | (3) |
|
4.4 Continuous Systems to Model the Human GIT |
|
|
96 | (11) |
|
4.5 Mucus-Immobilized Models of the Gut |
|
|
107 | (4) |
|
4.6 Models to Simulate Complex Host-Microbial Interactions |
|
|
111 | (2) |
|
4.7 Gastric-Small Intestine Model Systems |
|
|
113 | (7) |
|
|
120 | (17) |
5 Macronutrient Nutritional Functionality of Carbohydrates, Proteins and Lipids: Digestibility, Absorption and Interactions |
|
137 | (34) |
|
|
|
|
137 | (2) |
|
5.2 Applications and Considerations |
|
|
139 | (4) |
|
|
139 | (2) |
|
|
141 | (1) |
|
|
142 | (1) |
|
5.3 Simulating Digestive Processes |
|
|
143 | (7) |
|
5.3.1 Oral Food Processing and Implications for Sample Preparation |
|
|
143 | (2) |
|
|
145 | (2) |
|
5.3.3 Upper Intestinal Phase |
|
|
147 | (3) |
|
5.4 Interactions and Structural Considerations |
|
|
150 | (1) |
|
5.5 Post-Digestion Analysis |
|
|
151 | (3) |
|
|
154 | (8) |
|
|
154 | (6) |
|
5.6.1.1 INFOGEST Method for General Nutrient Digestion |
|
|
154 | (4) |
|
5.6.1.2 Englyst Method for Rate for Carbohydrate Digestion |
|
|
158 | (1) |
|
5.6.1.3 Streamlined Protein Digestibility |
|
|
159 | (1) |
|
5.6.1.4 pH Stat Method for Testing Emulsified Lipids |
|
|
160 | (1) |
|
|
160 | (2) |
|
5.7 Limitation of In vitro Digestion Tests |
|
|
162 | (1) |
|
|
163 | (1) |
|
|
164 | (7) |
6 In vitro Approaches for Investigating the Bioaccessibility and Bioavailability of Dietary Nutrients and Bioactive Metabolites |
|
171 | (30) |
|
Chureeporn Chitchumroonchokchai |
|
|
|
|
171 | (2) |
|
6.2 Static Models of In vitro Digestion |
|
|
173 | (3) |
|
6.3 Dynamic Models of In vitro Digestion |
|
|
176 | (1) |
|
6.4 Application of In vitro Digestion Method for Determining the Digestive Stability and Bioaccessibility of Dietary Compounds |
|
|
177 | (3) |
|
|
180 | (3) |
|
6.6 Examples of the Effects of Bioaccessible Dietary Compounds on the Functions of Absorptive Intestinal Epithelial Cells |
|
|
183 | (2) |
|
6.7 Coupling the In vitro Digestion and Caco-2 Cell Models |
|
|
185 | (2) |
|
6.8 Co-culture Models Using Caco-2 Cells |
|
|
187 | (5) |
|
|
192 | (1) |
|
|
192 | (9) |
7 In vitro Models for Testing Toxicity in the Gastrointestinal Tract |
|
201 | (18) |
|
|
|
201 | (2) |
|
7.2 Advantages of In vitro Tests |
|
|
203 | (1) |
|
7.3 Limitations of Established Cell Line Models |
|
|
204 | (1) |
|
|
205 | (2) |
|
7.5 Co-culture Cell Models |
|
|
207 | (2) |
|
|
209 | (1) |
|
|
210 | (4) |
|
7.8 Summary and Conclusions |
|
|
214 | (1) |
|
|
214 | (5) |
8 In vitro Methods for Assessing Food Protein Allergenicity |
|
219 | (44) |
|
|
|
|
|
219 | (1) |
|
8.2 Food Sensitization, Hypersensitivity and Allergy |
|
|
220 | (11) |
|
8.2.1 The Mechanism of Developing Food Hypersensitivities |
|
|
222 | (2) |
|
8.2.2 The Exposure to Allergens |
|
|
224 | (10) |
|
8.2.2.1 The Gastrointestinal (GI) Route |
|
|
225 | (6) |
|
8.2.2.2 The Respiratory Tract Route |
|
|
231 | (1) |
|
8.2.2.3 The Cutaneous Route |
|
|
231 | (1) |
|
8.3 Safety Needs and Regulatory Consideration in Detecting Allergens in Food |
|
|
231 | (3) |
|
8.4 In vitro Analytical Methods for Testing Known Allergens |
|
|
234 | (17) |
|
8.4.1 Protein-Based Approaches |
|
|
234 | (4) |
|
8.4.2 Immunoassay Approaches |
|
|
238 | (4) |
|
8.4.2.1 Enzyme-Linked Immunosorbent Assay (ELISA) |
|
|
238 | (2) |
|
8.4.2.2 Other Immunoassay-based Methods |
|
|
240 | (2) |
|
8.4.3 DNA-based Approaches |
|
|
242 | (1) |
|
|
242 | (1) |
|
|
242 | (1) |
|
8.4.4 Mass Spectrometry-based Approaches |
|
|
243 | (1) |
|
8.4.5 In vitro Cell-based Methods for the Prediction of Food Allergenicity |
|
|
243 | (3) |
|
8.4.6 In Silico Methods for the Prediction of Food Allergenicity |
|
|
246 | (5) |
|
|
251 | (12) |
9 Challenges of Linking In vitro Analysis to Flavor Perception |
|
263 | (42) |
|
|
|
|
263 | (1) |
|
|
264 | (5) |
|
9.2.1 Flavor Analysis Overview |
|
|
264 | (1) |
|
9.2.2 Significance of Aroma Compounds |
|
|
265 | (1) |
|
9.2.3 Challenges of Food Flavor Compounds |
|
|
266 | (3) |
|
9.3 Overview of Flavor Analysis Techniques |
|
|
269 | (4) |
|
9.3.1 Key Isolation Techniques |
|
|
269 | (1) |
|
9.3.2 Taste Compound Isolation |
|
|
270 | (1) |
|
9.3.3 Aroma Compound Isolation |
|
|
270 | (2) |
|
9.3.3.1 Solvent Extraction |
|
|
270 | (1) |
|
|
271 | (1) |
|
|
271 | (1) |
|
9.3.4 Taste Compound Detection |
|
|
272 | (1) |
|
9.3.5 Aroma Compound Separation and Detection |
|
|
272 | (1) |
|
9.4 Further Developments in Aroma Analysis |
|
|
273 | (9) |
|
9.4.1 Gas Chromatography-Olfactometry |
|
|
273 | (1) |
|
9.4.2 Interpretation of GC-Olfactometry Data |
|
|
274 | (3) |
|
9.4.3 Recent Advances in Aroma Extract Preparation |
|
|
277 | (1) |
|
9.4.4 Solid-Phase MicroExtraction |
|
|
277 | (2) |
|
9.4.5 Advances in Solvent Assisted Flavor Extraction |
|
|
279 | (1) |
|
9.4.6 Challenges of Single Aroma Compound Data Interpretation |
|
|
280 | (1) |
|
9.4.7 Correlation of the Sensory Experience with GC Data |
|
|
281 | (1) |
|
9.5 Recent Advances Developing In vitro Flavor Analysis Tools |
|
|
282 | (4) |
|
9.5.1 Electronic Devices for Flavor Assessment |
|
|
282 | (1) |
|
|
283 | (1) |
|
|
284 | (1) |
|
9.5.4 Further Developments in Electronic Flavor Devices |
|
|
285 | (1) |
|
|
286 | (1) |
|
9.7 Real Time Studies of Flavor Delivery |
|
|
287 | (5) |
|
9.8 Future Direction of In vitro Flavor Studies |
|
|
292 | (6) |
|
|
292 | (2) |
|
9.8.2 Taste Cell Model Systems |
|
|
294 | (1) |
|
|
295 | (1) |
|
|
296 | (1) |
|
9.8.5 Interaction Effects and Multi-modal Perception |
|
|
297 | (1) |
|
9.8.6 Brain Imaging by fMRI |
|
|
297 | (1) |
|
|
298 | (2) |
|
|
300 | (5) |
Index |
|
305 | |